Biocon: Syngene is Asia's fastest-growing CRO

Syngene, the CRO arm of Indian biotech giant Biocon, is poised to swell about 20% a year, Managing Director Kiran Mazumdar-Shaw said, making it the continent's fastest-growing service provider. Last year, Syngene grew about 36% to $102.7 million in revenue. Article

Suggested Articles

WuXi AppTec has cut the ribbon on its expanded Laboratory Testing Division in New Jersey as it looks to boost its integrated testing service portfolio.

St. Jude, Microsoft and DNAnexus have created a data-sharing and analysis platform to help accelerate pediatric cancer research.

The money will be used to expand its footprint in both China and the U.S., including a new R&D operation in Boston.